Science News

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Piersica announces it secured an Army SBIR Phase II contract worth approximately $1.9M to further develop its ultra-high energy battery solutions....

BALTIMORE--(BUSINESS WIRE)--Sinclair today announced a collaboration with the American Cancer Society (ACS) to launch Sinclair Cares: Help Drive Out Cancer, a nationwide campaign dedicated to raising awareness about the transportation barriers people with cancer face in accessing lifesaving treatment. The campaign spotlights the American Cancer Society Road To Recovery® program, which provides free rides to treatment for those in need, while encouraging volunteerism and financial support. As pa...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced a renewed $1.1 million investment in the YMCA of Central Ohio today to continue critical STEM initiatives through 2026. This extended partnership will provide access to learning opportunities for more than 44,000 children and families across Central Ohio. Building on Proven Success The latest partnership builds on the success of an initial two-year program that served more than 35,000 youth between 2022 and 2024, significantly surpassing its o...

CHICAGO--(BUSINESS WIRE)--Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ultrasound (CEUS) to help assess certain liver cancers and determine whether a liver is healthy enough for transplantation, according to experts affiliated with the International Contrast Ultrasound Society (ICUS). “This eliminates a significant roadblock to the appropriate use of CEUS at a time whe...

NEW YORK & WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision immunology, and Savant Bio, a Roivant-backed health data infrastructure company, today announced an expanded strategic partnership to build the world’s most advanced clinicogenomic dataset in rheumatoid arthritis (RA). The collaboration aims to generate high-resolution insights to support academic research, clinical trial design, therapeutic strategy, and real-world evidence generation. The collaboration centers...

PHILADELPHIA--(BUSINESS WIRE)--Kaizen Biosciences, Co., a biopharmaceutical company, today announced the acceptance of its abstract for presentation at IDWeek 2025, which serves as a premier forum for infectious disease (ID) professionals to knowledge-sharing around improving patient care and overall public health. In addition, the company recently presented new pharmacokinetic data at the International Society of Pharmacometrics (ISoP/ISOM) a biennially meeting, spotlighting a novel amoxicilli...

MADISON, Wis.--(BUSINESS WIRE)--Invenra, a biotechnology company specializing in next-generation multispecific antibody discovery and development, is pleased to announce the appointment of Dr. Alan J. Korman, PhD, FAIO, to its Scientific Advisory Board (SAB). Dr. Korman brings a wealth of experience in immuno-oncology, having played a pivotal role in the development of groundbreaking cancer immunotherapies. Dr. Korman is currently CSO and a member of the Board of Directors of Bluesphere Bio, a...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their voluntary licensing agreement with the Medicines Patent Pool (MPP) for cabotegravir to include patents relating to its use in a long-acting HIV treatment regimen. The announcement follows updated guidance from WHO recommending long-acting injectable cabotegravir + rilpivirine as an HIV treatment option. Existing generic l...

SAINT AUGUSTINE, Fla.--(BUSINESS WIRE)--Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago. Kihealth’s pioneering liquid-biopsy test, which measures the rate of pancreatic beta‑cell death, earned top honors among five finalists for its potential to revolutionize early diabetes detection. Dubbed the “Super Bowl of diabetes innovation,” this prestigious award ha...

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics began a clinical trial for its atopic dermatitis candidate, marking the first clinical trial of a topical IL-36 inhibitor....